Keebeck Wealth Management Invests $457,000 in HealthEquity, Inc. $HQY

Keebeck Wealth Management bought a new position in shares of HealthEquity, Inc. (NASDAQ:HQY) during the second quarter, Holdings Channel.com reports. The fund bought 5,061 shares of the company’s stock, valued at approximately $457,000.

A number of other large investors have also added to or reduced their stakes in the business. BlackRock Inc. acquired a new stake in HealthEquity during the 2nd quarter valued at $1,018,621,000. Wasatch Advisors LP boosted its position in HealthEquity by 10.5% during the second quarter. Wasatch Advisors LP now owns 7,960,735 shares of the company’s stock worth $719,014,000 after purchasing an additional 757,801 shares during the period. Geode Capital Management LLC increased its holdings in shares of HealthEquity by 0.3% in the fourth quarter. Geode Capital Management LLC now owns 2,201,232 shares of the company’s stock valued at $201,685,000 after purchasing an additional 5,671 shares during the last quarter. Westfield Capital Management Co. LP increased its holdings in shares of HealthEquity by 13.7% in the fourth quarter. Westfield Capital Management Co. LP now owns 1,952,452 shares of the company’s stock valued at $178,864,000 after purchasing an additional 235,794 shares during the last quarter. Finally, William Blair Investment Management LLC acquired a new position in shares of HealthEquity in the fourth quarter valued at $169,956,000. Institutional investors own 99.55% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on HQY shares. Barrington Research restated an “outperform” rating and set a $110.00 target price on shares of HealthEquity in a research note on Friday, May 22nd. KeyCorp reiterated an “overweight” rating on shares of HealthEquity in a research note on Tuesday, May 26th. Royal Bank Of Canada increased their price target on shares of HealthEquity from $100.00 to $108.00 and gave the company an “outperform” rating in a report on Wednesday, June 3rd. BTIG Research increased their price target on shares of HealthEquity from $110.00 to $115.00 and gave the company a “buy” rating in a report on Friday, July 24th. Finally, Citizens Jmp raised their price objective on shares of HealthEquity from $110.00 to $111.00 and gave the stock a “market outperform” rating in a research report on Monday, June 1st. Eleven research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $110.93.

Insider Buying and Selling

In other HealthEquity news, Director Gayle Furgurson Wellborn sold 2,439 shares of the stock in a transaction that occurred on Thursday, May 28th. The shares were sold at an average price of $90.00, for a total transaction of $219,510.00. Following the transaction, the director owned 19,733 shares in the company, valued at $1,775,970. This represents a 11.00% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Delano Ladd sold 7,500 shares of the stock in a transaction that occurred on Thursday, May 28th. The stock was sold at an average price of $90.00, for a total transaction of $675,000.00. Following the transaction, the executive vice president owned 91,141 shares in the company, valued at approximately $8,202,690. The trade was a 7.60% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 17,905 shares of company stock valued at $1,651,280. 1.60% of the stock is owned by company insiders.

HealthEquity Stock Performance

Shares of NASDAQ HQY opened at $105.41 on Friday. The company has a debt-to-equity ratio of 0.46, a current ratio of 3.44 and a quick ratio of 3.44. The firm has a market cap of $8.81 billion, a price-to-earnings ratio of 39.48, a P/E/G ratio of 1.75 and a beta of 0.21. The stock’s fifty day moving average price is $96.64 and its two-hundred day moving average price is $87.20. HealthEquity, Inc. has a one year low of $72.76 and a one year high of $107.62.

HealthEquity (NASDAQ:HQY) last posted its earnings results on Thursday, May 28th. The company reported $1.24 earnings per share for the quarter, topping analysts’ consensus estimates of $1.11 by $0.13. The company had revenue of $354.64 million during the quarter, compared to the consensus estimate of $352.02 million. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.The business’s quarterly revenue was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. On average, equities analysts forecast that HealthEquity, Inc. will post 3.92 EPS for the current year.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.